U.S. market Closed. Opens in 16 hours 49 minutes

IGMS | IGM Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312023-09-302023-03-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue2.13M1.85M1.07M1.07MN/AN/AN/AN/AN/A
Cost of Revenue8.28MN/AN/A10.60M7.72M3.58M2.33MN/AN/A
Gross Profit-6.15M1.85M1.07M-9.53M-7.72M-3.58M-2.33MN/AN/A
Operating Expenses257.31M256.46M229.03M229.03M165.32M83.28M44.50M22.79M11.15M
Selling, General & Admin50.07M50.11M49.74M49.74M38.30M18.25M9.24M3.83M2.51M
Research & Development207.24M206.35M179.29M179.29M127.03M65.03M35.26M18.96M8.64M
Other Operating Expenses-20.00K-78.00K-181.00K-181.00K159.00K1.93M1.36M80.00KN/A
Operating Income-263.46M-254.61M-227.96M-227.96M-165.32M-83.28M-44.50M-22.79M-11.15M
Other Expenses / Income17.72M-78.00K6.85M6.85M159.00K1.93M1.36M80.00K93.00K
Before Tax Income-245.74M-237.86M-221.10M-221.10M-165.16M-81.36M-43.13M-22.71M-11.05M
Income Tax Expenses678.00K-16.39M-6.85M-6.85M-4.48M-1.02M-597.00K80.00KN/A
Net Income-246.42M-238.30M-214.25M-214.25M-160.68M-80.33M-42.54M-22.71M-11.05M
Interest ExpensesN/AN/A-6.85M-6.85MN/AN/AN/AN/AN/A
Basic Shares Outstanding52.31MN/A41.54M41.54M33.48M30.75M9.00M7.39M7.39M
Diluted Shares Outstanding52.31MN/A41.54M41.54M33.48M30.75M9.00M7.39M7.39M
EBITDA-255.18M-246.61M-227.96M-227.96M-165.32M-83.28M-44.50M-22.51M-10.89M
EBITDA Margin-11,980.47%-13,323.18%-21,324.23%-21,324.23%0.00%0.00%0.00%0.00%0.00%
EBIT-245.74M-254.68M-227.96M-227.96M-165.16M-81.36M-43.13M-22.63M-11.05M
EBIT Margin-11,537.00%-13,759.27%-21,324.23%-21,324.23%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312023-09-302023-03-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙